Search for: "Teva Branded Pharmaceutical Products R" Results 1 - 20 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Oct 2024, 7:44 pm by Patent Docs
Noonan -- The Federal Circuit has been petitioned by plaintiff Teva Branded Pharmaceutical Products R&D, Inc. to reverse a decision in favor of Defendant Amneal Pharmaceuticals wherein the District Court entered an injunction ordering Teva to delist five Orange Book-listed patents, in Teva Pharms. [read post]
11 Nov 2024, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit has been petitioned by plaintiff Teva Branded Pharmaceutical Products R&D, Inc. to reverse a decision in favor of Defendant Amneal Pharmaceuticals, wherein the District Court entered an injunction ordering Teva to delist five Orange Book-listed patents, in Teva Pharms. [read post]
9 Sep 2012, 9:59 pm by Patent Docs
Teva Branded Pharmaceutical Products R&D Inc. et al. v. [read post]
17 Oct 2024, 9:59 pm by Patent Docs
Noonan -- The Federal Circuit has been petitioned by plaintiff Teva Branded Pharmaceutical Products R&D, Inc. to reverse a decision in favor of Defendant Amneal Pharmaceuticals wherein the District Court entered an injunction ordering Teva to delist five Orange Book-listed patents, in Teva Pharms. [read post]
3 Apr 2024, 1:07 pm by Bevin Newman
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
25 Sep 2008, 4:23 am
According to Teva's release, the company's G-CSF product, which will be marketed in Europe under the brand name TevaGrastim ® beginning in 2009, is the first G-CSF biosimilar to receive a marketing authorization in the EU.... [read post]
8 Nov 2024, 7:27 am by Dennis Crouch
David Taylor, Argument Preview - Teva Branded Pharmaceutical Products R&D, Inc. v. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
16 Jun 2015, 6:00 am
Teva Pharmaceutical Industries, Ltd. will make a total of $1.2B available to compensate purchasers, including drug wholesalers, pharmacies, and insurers, who overpaid because of Cephalon’s illegal conduct. [read post]
25 Oct 2011, 9:28 am by Jenna Greene
Court of Appeals for the 2nd Circuit that found a pay for delay deal between Bayer AG and Barr Pharmaceuticals (now owned by Teva Pharmaceuticals) to drop a patent lawsuit over the antibiotic Cipro did not violate antitrust laws. [read post]
13 Feb 2015, 12:00 pm by Greene LLP
AstraZeneca markets and sells pharmaceutical products in the United States, including a drug sold under the trade name Nexium. [read post]